GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
批准号:
2084001
负责人:
Eric Holmes
金额:
$6.75万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-09-01 至 1993-08-31
关键词:
adenocarcinoma colon neoplasms enzyme activity enzyme induction /repression gene expression glycolipids glycosyltransferase human tissue immunochemistry laboratory mouse laboratory rabbit membrane lipids molecular oncology neoplastic cell neoplastic transformation tissue /cell culture tumor antigens
中文摘要
糖脂代谢的急剧变化与
致癌性转化暗示了膜的特殊作用
糖脂在调节细胞生长和细胞识别中的作用。
这些变化产生肿瘤特异性膜抗原
其在诊断上是有用的,并作为潜在的靶点,
免疫疗法 虽然许多肿瘤的例子
抗原已被记录,但可用的信息不多
与生物合成的调节机制有关,
阻止这些碳水化合物结构在正常细胞中的表达,
细胞和组织,并被激活,以产生它们在联合
肿瘤发生 各种乳糖系列碳水化合物
抗原已经被描述存在于人腺癌中。
最近的证据表明,激活正常的
未表达的β 1导致3 N-乙酰葡糖胺转移酶
所需的乳糖系列链合成发生在结肠
上皮细胞,并导致这些抗原的积累。
本申请建议将这些观察结果扩展到
详细说明这种酶和其他相关酶活性的相互作用
通过合成各种末端结构,
发生在这些肿瘤中。 β 1导致3 N-
乙酰葡糖胺转移酶,其被激活
将被广泛研究。 这项活动将
特征在于腺癌细胞系,纯化以
来自可溶性来源如血清或牛奶的均匀性,
根据对酶的物理性质的研究,抗体将
这些抗体将用于研究
以分离编码该酶的cDNA克隆。 这然后将
导致研究基因表达的调节,
发育和肿瘤发生。
这些研究将提供有关
与肿瘤发生有关的生化变化
这引起了一系列重要的和潜在的有用的,
人肿瘤抗原、基于乳糖系列的碳水化合物抗原。
英文摘要
Dramatic changes in glycolipid metabolism associated with
oncogenic transformation implicate a specific role for membrane
glycolipids in regulation of cell growth and cellular recognition.
These changes give rise to tumor specific membrane antigens
which are useful diagnostically and as potential targets for
immunotherapy. Although many examples of these tumor
antigens have been documented, not much information is available
relating to the mechanism of regulation of biosynthesis which
prevents expression of these carbohydrate structures in normal
cells and tissues and is activated to produce them in association
with oncogenesis. A variety of lacto-series based carbohydrate
antigens have been described to occur in human adenocarcinomas.
Recent evidence has shown that activation of a normally
unexpressed beta 1 leads to 3N-acetyl-glucosaminyltransferase
required for lacto-series chain synthesis occurs in colonic
epithelial cells and results in accumulation of these antigens.
This application proposes to extend these observations to study in
detail interactions of this and other enzyme activities associated
with the synthesis of a variety of end-stage structures which
occur in these tumors. The beta 1 leads to 3N-
acetylglucosaminyltransferase which is activated in association
with oncogenesis will be extensively studied. This activity will be
characterized in adenocarcinoma cell lines, purified to
homogeneity from a soluble source such as serum or milk and this
enzyme studied in terms of its physical properties, antibodies will
be prepared against it and these antibodies will be used in studies
to isolate cDNA clones which encode the enzyme. This will then
lead to studies of the regulation of gene expression during both
development and oncogenesis.
These studies will provide further information relating to the
biochemical changes occurring in association with oncogenesis
which gives rise to an important and potentially useful series of
human tumor antigens, lacto-series based carbohydrate antigens.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
GDP-fucose:GM1 alpha 1----2fucosyltransferase is activated in parenchymal cells of rat liver during early stages of N-2-acetylaminofluorene induced hepatocarcinogenesis.
GDP-岩藻糖:GM1 α 1----2岩藻糖基转移酶在 N-2-乙酰氨基芴诱导的肝癌发生的早期阶段在大鼠肝实质细胞中被激活。
DOI:
10.1093/carcin/11.1.89
发表时间:
1990
期刊:
Carcinogenesis
影响因子:
4.7
作者:
[Holmes,EH]
通讯作者:
Holmes,EH
Brefeldin A induced inhibition of de novo globo- and neolacto-series glycolipid core chain biosynthesis in human cells. Evidence for an effect on beta 1-->4galactosyltransferase activity.
Brefeldin A 诱导抑制人类细胞中的从头球形和新乳糖系列糖脂核心链生物合成。
DOI:
--
发表时间:
1992
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Sherwood,AL, Holmes,EH]
通讯作者:
Holmes,EH
Characterization of two monoclonal antibodies specific for lacto-series type 1 chain Gal beta 1----3GlcNAc-terminal structures.
对乳系列 1 型链 Gal beta 1----3GlcNAc 末端结构具有特异性的两种单克隆抗体的表征。
DOI:
10.1016/0003-9861(90)90567-i
发表时间:
1990
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Holmes,EH, Greene,TG]
通讯作者:
Greene,TG
Biosynthesis of fucose containing lacto-series glycolipids in human colonic adenocarcinoma Colo 205 cells.
人结肠腺癌细胞 Colo 205 细胞中含岩藻糖的乳系列糖脂的生物合成。
DOI:
10.1016/0003-9861(89)90479-7
发表时间:
1989
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Holmes,EH, Levery,SB]
通讯作者:
Levery,SB
Stable expression of a cDNA encoding a human beta 1 --> 3galactosyltransferase responsible for lacto-series type 1 core chain synthesis in non-expressing cells: variation in the nature of cell surface antigens expressed.
编码人β1->3半乳糖基转移酶的cDNA在非表达细胞中稳定表达,该酶负责乳系列1型核心链的合成:表达的细胞表面抗原性质的变化。
DOI:
10.1002/jcb.240500207
发表时间:
1992
期刊:
Journal of cellular biochemistry
影响因子:
4
作者:
[Sherwood,AL, Greene,TG, Holmes,EH]
通讯作者:
Holmes,EH
共 20 条
ADMINISTRATIVE CORE
-
批准号:8360694
-
项目类别:
-
资助金额:$50.46万
-
财政年份:2011
-
负责人:Eric Holmes
-
依托单位:
INBRE II: Hawaii Statewide Research & Education Partnership (HSREP)
-
批准号:8137032
-
项目类别:
-
资助金额:$297.69万
-
财政年份:2001
-
负责人:Eric Holmes
-
依托单位:
Cellular Basis of Immunological and Neurological Disease
-
批准号:7471544
-
项目类别:
-
资助金额:$232.08万
-
财政年份:2001
-
负责人:Eric Holmes
-
依托单位:
INBRE II: Hawaii Statewide Research & Education Partnership (HSREP)
-
批准号:8288745
-
项目类别:
-
资助金额:$294.95万
-
财政年份:2001
-
负责人:Eric Holmes
-
依托单位:
INBRE II: Hawaii Statewide Research & Education Partnership (HSREP)
-
批准号:7900700
-
项目类别:
-
资助金额:$323.57万
-
财政年份:2001
-
负责人:Eric Holmes
-
依托单位:
ANTIBODY TARGETING TO PSMA IN PROSTATIC TUMORS
-
批准号:2776431
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:Eric Holmes
-
依托单位:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
-
批准号:6350191
-
项目类别:
-
资助金额:$34.97万
-
财政年份:1997
-
负责人:Eric Holmes
-
依托单位:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
-
批准号:2871891
-
项目类别:
-
资助金额:$33.68万
-
财政年份:1997
-
负责人:Eric Holmes
-
依托单位:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
-
批准号:2654220
-
项目类别:
-
资助金额:$33.06万
-
财政年份:1997
-
负责人:Eric Holmes
-
依托单位:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
-
批准号:2009747
-
项目类别:
-
资助金额:$32.46万
-
财政年份:1997
-
负责人:Eric Holmes
-
依托单位:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
-
批准号:6150220
-
项目类别:
-
资助金额:$34.31万
-
财政年份:1997
-
负责人:Eric Holmes
-
依托单位:
IMMUNOTOXIN THERAPY FOR PROSTATIC CARCINOMAS
-
批准号:2009407
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:Eric Holmes
-
依托单位:
SPECIFIC INHIBITORS OF SERINE/THREONINE PHOSPHATASES
-
批准号:2115749
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:Eric Holmes
-
依托单位:
MONOCLONAL ANTIBODIES TO DNA BASE LESIONS
-
批准号:2110761
-
项目类别:
-
资助金额:$9.92万
-
财政年份:1995
-
负责人:Eric Holmes
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3523527
-
项目类别:
-
资助金额:$0.66万
-
财政年份:1990
-
负责人:Eric Holmes
-
依托单位:
GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
-
批准号:3071860
-
项目类别:
-
资助金额:$6.75万
-
财政年份:1988
-
负责人:Eric Holmes
-
依托单位:
GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
-
批准号:3071858
-
项目类别:
-
资助金额:$5.18万
-
财政年份:1988
-
负责人:Eric Holmes
-
依托单位:
GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
-
批准号:3071859
-
项目类别:
-
资助金额:$5.4万
-
财政年份:1988
-
负责人:Eric Holmes
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3523303
-
项目类别:
-
资助金额:$0.5万
-
财政年份:1988
-
负责人:Eric Holmes
-
依托单位:
GLYCOSYLTRANSFERASE ACTIVATION IN COLONIC ADENOCARCINOMA
-
批准号:3071861
-
项目类别:
-
资助金额:$6.75万
-
财政年份:1988
-
负责人:Eric Holmes
-
依托单位:
海外基金